# KEWAUNEE SCIENTIFIC CORPORATION (KEQU) · Edgar & Edgarette company card

> Kewaunee Scientific (KEQU) grew revenue 17.3% in FY2026 to $282 million, operating margin 5.9% against a 12.5% median for laboratory apparatus & furniture, equity 41.9% of assets, and its dividend per share fell in the latest year on record. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 55529 · fiscal year ended 2026-04-30 · 5 audited years read · [page](https://www.pops4.com/boards/company/KEQU) · [JSON](https://www.pops4.com/boards/company/KEQU.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $282M |
| Revenue growth, 1 year | 17.3% |
| Revenue growth per year | 13.7% |
| Operating margin | 5.9% (prior year 7.4%) |
| Net margin | 3.7% |
| Operating cash flow | $19M |
| Capital spending | $4M |
| Free cash flow | $15M |
| Cash | $10M |
| Long-term debt | $20M |
| Total assets | $178M |
| Total equity | $75M |
| Equity ÷ assets | 41.9% |
| Return on equity | 14.0% |
| Dividend per share | $0.38 |
| Dividend years rising | 0 |

## Readings, computed from those figures

- Altman Z: 4.75 (safe zone)
- Piotroski F: 6 of 9 (solid)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $282.0M (FY2026), total debt $20.1M. Experience: revenue up 17.3% on the year, up 13.7% a year over 4 years; operating margin 5.9%, down from 7.4%. Soundness: equity 41.9% of assets, return on equity 14.0%, the dividend per share fell in the latest year on record. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $258.8M and $377.4M next year (method v4.1: its own 5-year record of growth weighed at 57% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $235.3M to $416.8M. A statistical range, not company guidance. Against peers (41 filers, $50M+ revenue, its industry group): operating margin 5.9% against a 12.5% median; growth 17.3% against 3.8%.

Range logged 2026-09-27, receipt deed43b761cc822a, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- 8-K · filed 2026-11-02 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/55529/000119312526442777/0001193125-26-442777-index.htm)
- 10-Q · filed 2026-09-11 · [filing](https://www.sec.gov/Archives/edgar/data/55529/000005552926000035/0000055529-26-000035-index.htm)
- 8-K · filed 2026-09-09 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/55529/000005552926000031/0000055529-26-000031-index.htm)
- 8-K · filed 2026-08-27 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/55529/000005552926000028/0000055529-26-000028-index.htm)
- 8-K · filed 2026-08-26 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/55529/000005552926000025/0000055529-26-000025-index.htm)
- 8-K · filed 2026-08-25 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/55529/000005552926000023/0000055529-26-000023-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000055529.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=55529

## Cite

POPS4, Edgar & Edgarette: KEWAUNEE SCIENTIFIC CORPORATION (KEQU) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/KEQU. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.